Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 310-079-6 | CAS number: 102242-48-8 The complex residue resulting from the vacuum distillation of C6-24 and C6-24 unsatd. fatty alcohols which is derived from hydrogenation of C6-24 and C6-24 unsatd. fatty acids methyl esters. It consists predominantly of satd. and unsatd. fatty alcohols having carbon numbers greater than C18, dimerization products, and long chain esters having carbon numbers greater than C32 and boils at > 250°C (482°F) at 10 torr.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Orientating repeated dose toxicity study, conducted prior to the implementation of currently acknowledged testing guidelines such as the OECD TG 408, and according to an in-house protocol. Even if the study conduct does not fulfill current requirements, suitable basic data were given.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
Materials and methods
- Principles of method if other than guideline:
- The study was an orientating repeated dose toxicity study conducted according to an in house protocol, prior to the implementation of currently acknowledged testing guidelines such as the OECD TG 408. A group of 20 male and 20 female Wistar rats received a single daily dose of 250 mg/kg bw/day of the test material by gavage (vehicle: 1% CMC), five days a week, for 84 days. A group of 20 male and 20 female rats were kept as controls and treated with the vehicle only. Additionally, satellite groups consisting of 10 males and 10 females per group were added. The animals were observed/examined for mortality, clinical symptoms, changes in body weight and body weight gain, changes in haematology, clinical chemistry and urine, changes in organ weights, gross pathology and histopathology.
- GLP compliance:
- no
- Limit test:
- yes
Test material
- Reference substance name:
- Alcohols, C6-24 and C6-24-unsatd., distn. residues
- EC Number:
- 310-079-6
- EC Name:
- Alcohols, C6-24 and C6-24-unsatd., distn. residues
- Cas Number:
- 102242-48-8
- Molecular formula:
- Not available due to the complexity of the substance
- IUPAC Name:
- Alcohols, C6-24 and C6-24-unsatd. even numbered, distn. residues
- Details on test material:
- - Name of test material (as cited in study report): Pernil RU
- Chemical designation: 18:1 fatty alkohol, unsaturated, distillation residue
- Physical state: brown liquid
- No more details provided
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Mus-Ratus Breeder, Brunntal, Germany
- Age at study initiation: approx. 40 days
- Weight at study initiation: males, 130 g; females, 118 g
- Housing: males were housed in groups of 2 to 3 animals and females in groups of 5 per cage
- Diet: Altromin pelleted diet (Altromin R- Pressling-Haltungsdiät Nr. 1324), ad libitum
- Water: tap water, ad libitum
- Acclimatization: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 - 23
- Humidity (%): 50 - 55
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 1%
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS
The test solution consisted of an emulsion of the test material using 1% CMC as vehicle and was prepared freshly each day. - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 12 - 13 weeks
- Frequency of treatment:
- 5 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
250 mg/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- The test group consisted of 20 male and 20 female animals; additionally, 10 animals of each sex were added as satellite group.
The control group consisted similarly of 20 + 10 animals per sex.
An additional control group consisted of 20 animals per sex; these animals were used for blood sampling. - Control animals:
- yes, concurrent vehicle
- Details on study design:
- Each animal of the test group received a single dosage of the test solution by gavage on 5 days per weeks. Similarly, each animal of the vehicle control groups received a single dosage of 1% CMC by gavage. The application volume was 10 mL/kg bw.
Examinations
- Observations and examinations performed and frequency:
- CLINICAL PARAMETERS
The rats were checked daily for mortality and clinical symptoms. The body weights were recorded once a week. No further parameters were considered.
HAEMATOLOGY AND CLINICAL CHEMISTRY
At test initiation, blood samples were collected from the additional control group, and at test ending, blood samples were collected from all animals. Following haematological parameters were considered:leukocyte count (WBC), erythrocyte count (RBC), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and differential blood count. Referring to clinical chemistry, following parameters were considered: sodium, potassium, urea, calcium, alkaline phosphatase, aspartate aminotransferase (GOT), alanine aminotransferase (GPT), glucose, and total protein.
URINALYSIS
At test initiation, urine was collected from the additional control group, and at test ending, urine was collected from all animals. For this purpose, the animals were placed individually in metabolism cages for 24 hours and received feed and water ad libitum. Following parameters were considered: volume, pH, protein, glucose, ketones, urobilinogen, blood, specific gravity, and sediment.
The amount of excreted feces during holding of the animals in the metabolism cages was recorded. - Sacrifice and pathology:
- NECROPSY
At test ending, all animals were sacrificed for the purpose of necropsy. The organs were macroscopically examined for gross pathological lesions or changes. The main organs were collected for determination of absolute weight. Following organs were fixed in formalin for the purpose of histopathological examination:
eyes, tongue, salivary glands, oesophagus, trachea, lungs, aorta, heart, lymph nodes, thymus, liver, pancreas, spleen, kidneys, fore stomach, glandular stomach, duodenum, colon, urinary bladder, testes, epididymides, adrenals, seminal vesicle, prostate, uterus, ovaries, thyroid, parathyroid, brain, skeletal muscle, skin, sciatic nerve
These organs/tissues were paraffin embedded, sectioned, and the sections were stained for purpose of light microscopy with hematoxylin and eosin. The organs and tissues of 6 animals per sex and group were finally subjected to histopathological examination. - Statistics:
- Calculation of means and standard deviations, statistical assessment of the significance by means of the t-test and the U-test.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- changes in GPT and GOT in treated females only
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- MORTALITY AND CLINICAL SYMPTOMS
Neither mortalities nor clinical symptoms indicating toxicity were noticed.
BODY WEIGHT
The body weight and body weight gain of the treated males over the testing period was similar to control, and thus, showed not treatment-related changes. For the treated females, a weak and transient decrease in body weight was noticed on week 11 of treatment, but was not considered to be due to treatment.
HAEMATOLOGY
At test ending the haematocrit value for the treated male animals was significantly increased compared to control and both, treated males and females showed an increase in MCV. Nevertheless, the measured values still were within the range considered as normal for the strain used and the age of the animals. Thus, the findings were not considered to be adverse effects due to treatment.
CLINICAL CHEMISTRY
The treated female animals showed a weak increase in alanine aminotransferase (GPT), which however was not to be considered as an adverse effect. In five treated females, a clear increase in aspartate aminotransferase (GOT) was noticed, which was considered to be treatment-related. The alkaline phosphase (AP) also was significantly increased in the treated female animals, however, this was almost due to one animal showing a high AP level. The alkaline phosphase (AP) also was increased in the treated males, but the finding was considered to be incidental and not due to treatment since the measured values did not indicate that the finding was adverse. The treated female animals further showed a significant decrease in sodium level.
URINALYSIS
In both, the treated and control groups, some animals of both sexes showed slight increased protein content and ketones in the urine, and occasionally blood cells were found. These findings were incidental and related to the strain used and the age of the animals; they were not treatment-related.
FECES
No difference in excretion was noticed between treated and control animals.
NECROPSY
At necropsy, neither organ weighing nor the gross and histological examination of organs and tissues revealed any treatment-related changes.
In fact, it was reported that at necropsy all animals showed signs of respiratory infection such as tracheitis. Furthermore, it was noticed that in the liver of nearly all animals, signs of lysis (almost low grade) of the hepatocytes were observed, and more often in females, intrahepatocytic pigment accumulation also was seen. In addition, some animals further displayed subcapsular lymphohistiocytic granuloma. Nevertheless, all these findings were equally distributed between treated and control animals, and thus, no relationship to treatment could be evidenced.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 250 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no clear treatment-related effects could be evidenced at the dose level of 250 mg/kg bw/day
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.